SCHEMBL19081582

SCHEMBL19081582

c1ccc2cc(-c3c4ccccc4c(-c4ccc(-c5c6oc7cc8ccccc8cc7c6cc6oc7ccccc7c56)cc4)c4ccccc34)ccc2c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
AHR P35869 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
HCRTR1 O43613 1/20 0.32
ESR1 P03372 2/20 0.31
ESR2 Q92731 2/20 0.31
GPR84 Q9NQS5 1/20 0.31
HPGD P15428 4/20 0.31
KDM4E B2RXH2 3/20 0.31
MEN1 O00255 3/20 0.31
ALDH1A1 P00352 3/20 0.31
MAPT P10636 3/20 0.31
KMT2A Q03164 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081596 0.95 NPC1 (0.33) NPC1RAB9ACYP1A1CYP1B1CYP1A2
SCHEMBL17944783 0.94 CYP1A1 (0.36) NPC1RAB9ACYP1A1CYP1B1CYP1A2
SCHEMBL17932174 0.92 CYP1A1 (0.37) NPC1RAB9ACYP1A1CYP1B1CYP1A2
SCHEMBL19081666 0.90 ALOX5 (0.34) RAB9ACYP1A1CYP1B1CYP1A2CYP2C19
SCHEMBL19081485 0.90 PGR (0.34) NPC1RAB9ACYP1A1CYP1B1CYP1A2
SCHEMBL17944520 0.89 ALOX5 (0.36) NPC1RAB9ACYP1A1CYP1B1CYP1A2
SCHEMBL17944837 0.89 AHR (0.36) NPC1RAB9ACYP1A1CYP1B1CYP1A2
SCHEMBL17944472 0.89 CYP1A1 (0.36) NPC1RAB9ACYP1A1CYP1B1CYP1A2
SCHEMBL19081434 0.88 ESR1 (0.38) NPC1RAB9ACYP1A1CYP1B1CYP1A2
SCHEMBL17932100 0.86 ESR1 (0.36) NPC1RAB9ACYP1A1CYP1B1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 NPC1 1508/4885RAB9A 3068/4885CYP1A1 184/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 NPC1 1508/4885RAB9A 3068/4885CYP1A1 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.